Haoxi Health Technology (HAO) Common Equity (2023 - 2025)

Haoxi Health Technology's Common Equity history runs 3 years deep, the most recent figure standing at $16.0 million for Q4 2025.

• On a quarterly basis, Common Equity fell 14.86% year-over-year to $16.0 million in Q4 2025; TTM through Dec 2025 was $16.0 million, a 14.86% decrease from a year earlier, with the FY2025 full-year figure at $17.4 million, up 54.16% from the prior year.
• Common Equity slipped to $16.0 million in Q4 2025 per HAO's latest filing, from $17.4 million in the prior quarter.
• Across five years, Common Equity topped out at $18.7 million in Q4 2024 and bottomed at $1.6 million in Q2 2023.
• The 3-year median for Common Equity is $16.0 million (2025), against an average of $13.0 million.
• Across the five-year window, Common Equity jumped 619.56% in 2024 and dropped 14.86% in 2025, its largest moves.
• Year by year, Common Equity stood at $1.6 million in 2023, then soared by 1096.47% to $18.7 million in 2024, then declined by 14.86% to $16.0 million in 2025.
• Per Business Quant, the three latest HAO Common Equity figures stand at $16.0 million (Q4 2025), $17.4 million (Q2 2025), and $18.7 million (Q4 2024).